Article ; Online: Diabetes and COVID-19: The past, the present, and the future.
Metabolism: clinical and experimental
2021 Volume 121, Page(s) 154814
Abstract: ... diabetes, should be prioritized for vaccination. In the future, as the pandemic fades, the prevalence ... patients requiring tight glucose control. Back and forth dilemma in the past with regards to continue ... with a poor prognosis in COVID-19. Scrupulous blood sugar management is crucial, since the worse outcomes are ...
| Abstract | Diabetes, one of the most prevalent chronic diseases in the world, is strongly associated with a poor prognosis in COVID-19. Scrupulous blood sugar management is crucial, since the worse outcomes are closely associated with higher blood sugar levels in COVID-19 infection. Although recent observational studies showed that insulin was associated with mortality, it should not deter insulin use in hospitalized patients requiring tight glucose control. Back and forth dilemma in the past with regards to continue/discontinue certain medications used in diabetes have been mostly resolved. The initial fears of consequences related to continuing certain medications have been largely dispelled. COVID-19 also necessitates the transformation in diabetes care through the integration of technologies. Recent advances in health-related technologies, notably telemedicine and remote continuous glucose monitoring, have become essential in the management of diabetes during the pandemic. Today, these technologies have changed the landscape of medicine and become more important than ever. Being a high-risk population, patients with type 1 or type 2 diabetes, should be prioritized for vaccination. In the future, as the pandemic fades, the prevalence of non-communicable diseases is expected to rise due to lifestyle changes and medical issues/dilemma encountered during the pandemic. |
|---|---|
| MeSH term(s) | Blood Glucose/metabolism ; Blood Glucose Self-Monitoring ; COVID-19/complications ; COVID-19/epidemiology ; COVID-19/mortality ; COVID-19/prevention & control ; COVID-19 Vaccines/administration & dosage ; Diabetes Mellitus, Type 1/complications ; Diabetes Mellitus, Type 1/drug therapy ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Disease Susceptibility ; Humans ; Hypoglycemic Agents/therapeutic use ; Pandemics ; SARS-CoV-2/isolation & purification |
| Chemical Substances | Blood Glucose ; COVID-19 Vaccines ; Hypoglycemic Agents |
| Language | English |
| Publishing date | 2021-06-11 |
| Publishing country | United States |
| Document type | Journal Article ; Review |
| ZDB-ID | 80230-x |
| ISSN | 1532-8600 ; 0026-0495 |
| ISSN (online) | 1532-8600 |
| ISSN | 0026-0495 |
| DOI | 10.1016/j.metabol.2021.154814 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Uc I Zs.316: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.